{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:05:17Z","timestamp":1793394317582,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07593-x","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:26:00Z","timestamp":1770888360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Can MicroRNAs serve as reliable biomarkers and novel therapeutic targets in age-related macular degeneration? A systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Kai-Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi-Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"7593_CR1","doi-asserted-by":"crossref","unstructured":"Mody S, Joshi A. Agerelated macular degeneration and its association with neurodegenerative disorders. Cureus. 2023;15(2).","DOI":"10.7759\/cureus.34920"},{"key":"7593_CR2","doi-asserted-by":"publisher","unstructured":"Chen KY, Chan HC, Chan CM. Can gene therapy transform the treatment landscape of posterior segment eye diseases? A comprehensive review of recent advancements. (in Eng) Drugs. 2025, Dec;85(12):1585\u2013608. https:\/\/doi.org\/10.1007\/s40265-025-02237-2.","DOI":"10.1007\/s40265-025-02237-2"},{"key":"7593_CR3","doi-asserted-by":"publisher","unstructured":"Chen KY, Chan HC, Chan CM. How has global research on neural degeneration in glaucoma evolved from 1977 to 2025? A pioneering bibliometric insight into trends, impact, and future directions. (in Eng) Int Ophthalmol. 45(1):335. Aug 13 2025 https:\/\/doi.org\/10.1007\/s10792-025-03700-5.","DOI":"10.1007\/s10792-025-03700-5"},{"key":"7593_CR4","doi-asserted-by":"publisher","unstructured":"Zhu Y, et al. Global, regional, and national Burden of age-related macular degeneration from 1990 to 2021 and projections to, 2040: a systematic analysis of the Global Burden of disease study 2021,\u201d Available at SSRN 5140915, 2025, doi: https:\/\/doi.org\/10.2139\/ssrn.5140915.","DOI":"10.2139\/ssrn.5140915"},{"key":"7593_CR5","unstructured":"Korva-Gurung I. Neovascular age-related macular degeneration: incidence, prevalence, treatment outcomes and quality of life. Urn.fi. 2024. https:\/\/oulurepo.oulu.fi\/handle\/10024\/50131"},{"key":"7593_CR6","doi-asserted-by":"crossref","unstructured":"Casciano F, et al. Retinal alterations predict early prodromal signs of neurodegenerative disease. Int J Mol Sci. 2024;25(3):1689.","DOI":"10.3390\/ijms25031689"},{"key":"7593_CR7","doi-asserted-by":"publisher","unstructured":"Chen KY, Chan HC, Chan CM. Can artificial intelligence with multimodal imaging outperform traditional methods in predicting age-related macular degeneration progression? A systematic review and exploratory meta-analysis,\u201d (in eng). BMC Med Inf Decis Mak. 2025, Sep, 1;25(1):321. https:\/\/doi.org\/10.1186\/s12911-025-03119-z.","DOI":"10.1186\/s12911-025-03119-z"},{"key":"7593_CR8","doi-asserted-by":"crossref","unstructured":"Flores R, Carneiro \u00c2, Tenreiro S, Seabra MC. Retinal progression biomarkers of early and intermediate agerelated macular degeneration. Life. 2021;12(1):36.","DOI":"10.3390\/life12010036"},{"key":"7593_CR9","doi-asserted-by":"crossref","unstructured":"Khan KN, et al. Differentiating drusen: drusen and drusenlike appearances associated with ageing, agerelated macular degeneration, inherited eye disease and other pathological processes. Prog Retin Eye Res. 2016;53:70\u2013106.","DOI":"10.1016\/j.preteyeres.2016.04.008"},{"key":"7593_CR10","doi-asserted-by":"crossref","unstructured":"Bhutto I, Lutty G. Understanding agerelated macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex. Mol Aspects Med. 2012;33(4):295\u2013317.","DOI":"10.1016\/j.mam.2012.04.005"},{"key":"7593_CR11","doi-asserted-by":"crossref","unstructured":"Danis RP, Lavine JA, Domalpally A. Geographic atrophy in patients with advanced dry agerelated macular degeneration: current challenges and future prospects. Clin Ophthalmol. 2015;2159\u201374.","DOI":"10.2147\/OPTH.S92359"},{"issue":"1","key":"7593_CR12","doi-asserted-by":"publisher","first-page":"7420637","DOI":"10.1155\/2016\/7420637","volume":"2016","author":"FM Luisa","year":"2016","unstructured":"Luisa FM, Octavio LG. Relationship between oxidative stress, circadian rhythms, and AMD. Oxida\ttive Med Cellular Longevity. 2016;2016(1):7420637.","journal-title":"Oxidative Med And Cellular Longevity"},{"issue":"10","key":"7593_CR13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1001\/jamaophthalmol.2017.3195","volume":"135","author":"E Kersten","year":"2017","unstructured":"Kersten E, et al. Phenotype characteristics of patients with agerelated macular degeneration carrying a rare variant in the complement factor H gene. JAMA Ophthalmol. 2017;135(10):1037\u201344.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"7593_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","volume":"22","author":"AN Witmer","year":"2003","unstructured":"Witmer AN, Vrensen G, Noorden V, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retinal Eye Res. 2003;22(1):1\u201329.","journal-title":"Prog In Retinal And Eye Res"},{"issue":"23","key":"7593_CR15","doi-asserted-by":"publisher","first-page":"13053","DOI":"10.3390\/ijms252313053","volume":"25","author":"N Marchesi","year":"2024","unstructured":"Marchesi N, Capierri M, Pascale A, Barbieri A. Different therapeutic approaches for dry and wet AMD. Int J Mol Sci. 2024;25(23):13053.","journal-title":"Int J Mol Sci"},{"key":"7593_CR16","doi-asserted-by":"publisher","first-page":"101389","DOI":"10.1016\/j.mam.2025.101389","volume":"105","author":"KY Chen","year":"2025","unstructured":"Chen KY, Chan HC, Chan CM. Unveiling the P2X7 receptor: exploring its mechanisms, pathogenic role in ocular diseases, and emerging therapeutic potential. (in Eng), Mol Aspects Med. 2025, Oct;105:101389. https:\/\/doi.org\/10.1016\/j.mam.2025.101389.","journal-title":"(In Eng), Mol Aspects Med"},{"issue":"3","key":"7593_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gpb.2016.12.005","volume":"15","author":"IM Dykes","year":"2017","unstructured":"Dykes IM, Emanueli C. Transcriptional and posttranscriptional gene regulation by long noncoding rna. Genomics, Proteomics Bioinf. 2017;15(3):177\u201386.","journal-title":"Genomics, Proteomics Bioinf"},{"issue":"2","key":"7593_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ceb.2008.01.006","volume":"20","author":"J Liu","year":"2008","unstructured":"Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin In Cell Biol. 2008;20(2):214\u201321.","journal-title":"Curr Opin In Cell Biol"},{"issue":"1","key":"7593_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.tins.2021.10.008","volume":"45","author":"SW Du","year":"2022","unstructured":"Du SW, Palczewski K. MicroRNA regulation of critical retinal pigment epithelial functions. Trends Neurosciences. 2022;45(1):78\u201390.","journal-title":"Trends In Neurosciences"},{"issue":"10","key":"7593_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tcb.2013.05.004","volume":"23","author":"M Agathocleous","year":"2013","unstructured":"Agathocleous M, Harris WA. Metabolism in physiological cell proliferation and differentiation. Trends Cell Biol. 2013;23(10):484\u201392.","journal-title":"Trends In Cell Biol"},{"issue":"1","key":"7593_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12929-024-01036-3","volume":"31","author":"B Martins","year":"2024","unstructured":"Martins B, Pires M, Francisco AA, Gir\u00e3o H, Fernandes R. Contribution of extracellular vesicles for the pathogenesis of retinal diseases: shedding light on bloodretinal barrier dysfunction. J Biomed Sci. 2024;31(1):48.","journal-title":"J Biomed Sci"},{"issue":"4","key":"7593_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.14336\/AD.2019.0809","volume":"11","author":"K Kaarniranta","year":"2020","unstructured":"Kaarniranta K, Pawlowska E, Szczepanska J, Blasiak J. DICER1 in the pathogenesis of agerelated macular degeneration (AMD)Alu rna accumulation versus miRNA dysregulation. Aging Dis. 2020;11(4):851.","journal-title":"Aging And Disease"},{"issue":"1","key":"7593_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3892\/ijmm.2022.5210","volume":"51","author":"Z Liao","year":"2022","unstructured":"Liao Z, Zheng R, Shao G. Mechanisms and application strategies of miRna146a regulating inflammation and fibrosis at molecular and cellular levels. Int J Mol Med. 2022;51(1):7.","journal-title":"Int J Mol Med"},{"key":"7593_CR24","doi-asserted-by":"crossref","unstructured":"Zhou Q, Gallagher R, UfretVincenty R, Li X, Olson EN, Wang S. Regulation of angiogenesis and choroidal neovascularization by members of microRNA23\u223c 27\u223c 24 clusters. Proceedings of the national academy of sciences. 2011), 8287\u201392, 108(20.","DOI":"10.1073\/pnas.1105254108"},{"issue":"1","key":"7593_CR25","doi-asserted-by":"publisher","first-page":"112737","DOI":"10.1016\/j.yexcr.2021.112737","volume":"406","author":"A Bereimipour","year":"2021","unstructured":"Bereimipour A, Najafi H, Sadat ME, Moradi S, Satarian L. Roles of miR204 in retinal development and maintenance. Exp Cell Res. 2021;406(1):112737.","journal-title":"Exp Cell Res"},{"issue":"14","key":"7593_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1167\/iovs.66.14.53","volume":"66","author":"KY Chen","year":"2025","unstructured":"Chen KY, Chan HC, Chan CM. Can immune checkpoint modulation redefine ocular immunotherapy? Emerging mechanisms, challenges, and translational opportunities-A comprehensive review. (in Eng), Invest Ophthalmol Vis Sci. 2025, Nov, 3;66(14):53. https:\/\/doi.org\/10.1167\/iovs.66.14.53.","journal-title":"(In Eng), Invest Ophthalmol Vis Sci"},{"issue":"8","key":"7593_CR27","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1021\/cr300362f","volume":"113","author":"H Dong","year":"2013","unstructured":"Dong H, Lei J, Ding L, Wen Y, Ju H, Zhang X. MicroRNA: function, detection, and bioanalysis. Chem Rev. 2013;113(8):6207\u201333.","journal-title":"Chem Rev"},{"issue":"34","key":"7593_CR28","doi-asserted-by":"publisher","first-page":"22793","DOI":"10.1021\/acsnano.4c08486","volume":"18","author":"Y Su","year":"2024","unstructured":"Su Y, Chen M, Xu W, Gu P, Fan X. Advances in extracellular vesicles-based diagnostic and therapeutic approaches for ocular diseases. ACS Nano. 2024;18(34):22793\u2013828.","journal-title":"ACS Nano"},{"issue":"12","key":"7593_CR29","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3390\/jpm11121329","volume":"11","author":"AI Oca","year":"2021","unstructured":"Oca AI, et al. Predictive biomarkers of agerelated macular degeneration response to antiVEGF treatment. J Personalized Med. 2021;11(12):1329.","journal-title":"J Personalized Med"},{"issue":"3","key":"7593_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4155\/fmc.11.176","volume":"4","author":"S Wang","year":"2012","unstructured":"Wang S, Koster KM, He Y, Zhou Q. miRnas as potential therapeutic targets for agerelated macular degeneration. Future Med Chem. 2012;4(3):277\u201387.","journal-title":"Future Med Chem"},{"key":"7593_CR31","doi-asserted-by":"publisher","unstructured":"Chen KY, Chan HC, Chan CM. Can microRNAs serve as diagnostic biomarkers for glaucoma? A systematic review and meta-analysis of their diagnostic significance. Mol Diagn Ther. 2025.Epub ahead of print. PMID: 41454211. https:\/\/doi.org\/10.1007\/s40291-025-00818-1","DOI":"10.1007\/s40291-025-00818-1"},{"issue":"6","key":"7593_CR32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.survophthal.2025.05.008","volume":"70","author":"KY Chen","year":"2025","unstructured":"Chen KY, Chan HC, Chan CM. Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: a systematic review and network meta-analysis of randomized controlled trials. (in Eng) Surv Ophthalmol. 2025, Nov-Dec;70(6):1067\u201389. https:\/\/doi.org\/10.1016\/j.survophthal.2025.05.008.","journal-title":"Surv Ophthalmol"},{"key":"7593_CR33","doi-asserted-by":"crossref","unstructured":"O\u2019Dea RE, et al. Preferred reporting Items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension. Biol Rev. 2021;96(5).","DOI":"10.1111\/brv.12721"},{"key":"7593_CR34","doi-asserted-by":"crossref","unstructured":"Methley AM, Campbell S, ChewGraham C, McNally R, Cheraghi-Sohi S. Pico, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14(1):1\u201310.","DOI":"10.1186\/s12913-014-0579-0"},{"issue":"9","key":"7593_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u201305. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"7593_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13643-020-01490-8","volume":"9","author":"SM Eick","year":"2020","unstructured":"Eick SM, Goin DE, Chartres N, Lam J, Woodruff TJ. \u201cAssessing risk of bias in human environmental epidemiology studies using three tools: different conclusions from different tools,\u201d (in eng). Syst Rev. 2020, Oct, 29;9(1):249. https:\/\/doi.org\/10.1186\/s13643-020-01490-8.","journal-title":"Syst Rev"},{"issue":"8","key":"7593_CR37","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1398-9995.2009.02083.x","volume":"64","author":"JL Bro\u017cek","year":"2009","unstructured":"Bro\u017cek JL, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 2 of 3. The grade approach to grading quality of evidence about diagnostic tests and strategies. Allergy. 2009;64(8):1109\u201316.","journal-title":"Allergy"},{"key":"7593_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-025-08581-1","author":"KY Chen","year":"2025","unstructured":"Chen KY, Chan HC, Chan CM. Does retinal vascular occlusion increase the risk of dementia? A pioneering systematic review and meta-analysis. (in Eng), Neurol Sci. 2025, Oct, 24. https:\/\/doi.org\/10.1007\/s10072-025-08581-1.","journal-title":"(In Eng), Neurol Sci"},{"key":"7593_CR39","doi-asserted-by":"publisher","unstructured":"Bhattacharjee S, Zhao Y, Dua P, Rogaev EI, Lukiw WJ. microRNA-34a-mediated down-regulation of the microglial-enriched triggering receptor and phagocytosis-sensor TREM2 in age-related macular degeneration. PLoS One. 2016;11(3):e0150211. https:\/\/doi.org\/10.1371\/journal.pone.0150211. Erratum in: PLoS One. 2016;11(4):e0153292. PMID: 26949937; PMCID: PMC4780721. https:\/\/doi.org\/10.1371\/journal.pone.0153292.","DOI":"10.1371\/journal.pone.0150211"},{"issue":"12","key":"7593_CR40","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1111\/jcmm.14731","volume":"23","author":"J Blasiak","year":"2019","unstructured":"Blasiak J, et al. Expression of VEGFA-regulating miRnas and mortality in wet AMD. J Cellular Mol Med. 2019;23(12):8464\u201371. https:\/\/doi.org\/10.1111\/jcmm.14731.","journal-title":"J Cellular And Mol Med"},{"issue":"6","key":"7593_CR41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/00365513.2019.1637931","volume":"79","author":"A Elbay","year":"2019","unstructured":"Elbay A, Ercan \u00c7, Akba\u015f F, Bulut H, Hakan \u00d6. Three new circulating microRNAs may be associated with wet age-related macular degeneration. Scand J Clin Lab Investigation. 2019;79(6):388\u201394. https:\/\/doi.org\/10.1080\/00365513.2019.1637931.","journal-title":"Scand J Clin Lab Investigation"},{"issue":"2","key":"7593_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.10.2.12","volume":"10","author":"H ElShelmani","year":"2021","unstructured":"ElShelmani H, Wride MA, Saad T, Rani S, Kelly DJ, Keegan D. The role of deregulated MicroRNAs in age-related macular degeneration pathology. Transl Vis Sci Technol. 2021;10(2):12. https:\/\/doi.org\/10.1167\/tvst.10.2.12.","journal-title":"Transl Vision Sciamp; Technol"},{"issue":"22","key":"7593_CR43","doi-asserted-by":"publisher","first-page":"12321","DOI":"10.3390\/ijms222212321","volume":"22","author":"H ElShelmani","year":"2021","unstructured":"ElShelmani H, Brennan I, Kelly DJ, Keegan D. Differential Circulating MicroRNA expression in Age-related macular degeneration. Int J Mol Sci. 2021;22(22):12321. https:\/\/doi.org\/10.3390\/ijms222212321.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"7593_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/tvst.9.4.28","volume":"9","author":"H ElShelmani","year":"2020","unstructured":"ElShelmani H, Wride MA, Saad T, Rani S, Kelly DJ, Keegan D. \u201cIdentification of novel serum MicroRNAs in age-related macular degeneration,\u201d (in Eng). Transl Vis Sci Technol. 2020, Mar;9(4):28. https:\/\/doi.org\/10.1167\/tvst.9.4.28.","journal-title":"Transl Vis Sci Technol"},{"key":"7593_CR45","first-page":"1057","volume":"20","author":"S Ertekin","year":"2014","unstructured":"Ertekin S, Y\u0131ld\u0131r\u0131m O, Din\u00e7 E, Ayaz L, Fidanc\u0131 SB, Tamer L. Evaluation of circulating miRnas in wet age-related macular degeneration. Mol Vision. 2014. [Online]. Available: 20:1057\u201366. https:\/\/pubmed.ncbi.nlm.nih.gov\/25221421\/.","journal-title":"Mol Vision"},{"issue":"7","key":"7593_CR46","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/humu.23226","volume":"38","author":"M Ghanbari","year":"2017","unstructured":"Ghanbari M, et al. Genetic variants in microRNAs and their binding sites within gene 3\u2032UTRs associate with susceptibility to age-related macular degeneration. Hum Mutat. 2017;38(7):827\u201338. https:\/\/doi.org\/10.1002\/humu.23226.","journal-title":"Hum Mutat"},{"issue":"9","key":"7593_CR47","doi-asserted-by":"publisher","first-page":"e107461","DOI":"10.1371\/journal.pone.0107461","volume":"9","author":"F Grassmann","year":"2014","unstructured":"Grassmann F, et al. A Circulating MicroRNA profile is associated with late-stage Neovascular Age-related macular degeneration. PLoS One. 2014;9(9):e107461\u2013107461. https:\/\/doi.org\/10.1371\/journal.pone.0107461.","journal-title":"PLoS One"},{"issue":"8","key":"7593_CR48","first-page":"5250","volume":"58","author":"DJ Keegan","year":"2017","unstructured":"Keegan DJ, ElShelmani H, Wride M. Identification of microRNA biomarkers in AMD. Invest Ophthalmol Visual Sci. 2017. [Online]. Available: 58(8):5250\u20135250. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2642116.","journal-title":"Invest Ophthalmol Visual Sci"},{"issue":"7","key":"7593_CR49","first-page":"809","volume":"56","author":"C Menard","year":"2015","unstructured":"Menard C, Paul J, Guire VD, Mike SP. Micro-RNA signatures in the vitreous and plasma of patients suffering from exudative AMD. Invest Ophthalmol Visual Sci. 2015. [Online]. Available: 56(7):809\u2013809. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2336534.","journal-title":"Invest Ophthalmol Visual Sci"},{"issue":"15","key":"7593_CR50","doi-asserted-by":"publisher","first-page":"19171","DOI":"10.18632\/oncotarget.8280","volume":"7","author":"C M\u00e9nard","year":"2016","unstructured":"M\u00e9nard C, et al. MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD. Oncotarget. 2016;7(15):19171\u201384. https:\/\/doi.org\/10.18632\/oncotarget.8280.","journal-title":"Oncotarget"},{"issue":"23","key":"7593_CR51","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1111\/febs.13066","volume":"281","author":"N Murad","year":"2014","unstructured":"Murad N, et al. miR-184 regulates ezrin, LAMP-1 expression, affects phagocytosis in human retinal pigment epithelium and is downregulated in age-related macular degeneration. FEBS J. 2014;281(23):5251\u201364. https:\/\/doi.org\/10.1111\/febs.13066.","journal-title":"The FEBS J"},{"issue":"13","key":"7593_CR52","first-page":"1328","volume":"55","author":"AT Nguyen","year":"2014","unstructured":"Nguyen AT, Smit-McBride Z, Bordbari M, Patel AP, Telander DG, Morse LS. Circulatory MicroRNAs in serum as potential biomarkers for AMD. Invest Ophthalmol Visual Sci. 2014. [Online]. Available: 55(13):1328\u20131328. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2266547.","journal-title":"Invest Ophthalmol Visual Sci"},{"issue":"7","key":"7593_CR53","first-page":"812","volume":"56","author":"AT Nguyen","year":"2015","unstructured":"Nguyen AT, Smit-McBride Z, Patel AP, Telander D, Morse LS. Differentially expressedmicroRNAs in serum of patients with wet and dry AMD. Invest Ophthalmol Visual Sci. 2015. [Online]. Available: 56(7):812\u2013812. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2336538.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"7593_CR54","unstructured":"Peterson-Burch FM. miRnas related to Age-related macular degeneration, given genetic susceptibility - D-Scholarship@Pitt. Pitt.edu. 2022, doi: https:\/\/d-scholarship.pitt.edu\/43930\/1\/FPeterson-Burch_Master.pdf."},{"key":"7593_CR55","doi-asserted-by":"publisher","unstructured":"Pogue AI, Lukiw WJ. Up-regulated pro-inflammatory MicroRNAs (miRnas) in Alzheimer\u2019s disease (ad) and age-related macular degeneration (AMD). Cell Mol Neurobiol. 2018;38(5):1021\u201331. https:\/\/doi.org\/10.1007\/s10571-017-0572-3.","DOI":"10.1007\/s10571-017-0572-3"},{"issue":"4","key":"7593_CR56","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1159\/000467941","volume":"41","author":"C Ren","year":"2017","unstructured":"Ren C, et al. Circulating miRnas as potential biomarkers of age-related macular degeneration. Cellular Physiol Biochem. 2017;41(4):1413\u201323. https:\/\/doi.org\/10.1159\/000467941.","journal-title":"Cellular Physiol And Biochem"},{"key":"7593_CR57","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.12659\/msm.893697","volume":"21","author":"M Szemraj","year":"2015","unstructured":"Szemraj M, et al. Serum MicroRNAs as potential biomarkers of AMD. Med Sci Monit. 2015;21:2734\u201342. https:\/\/doi.org\/10.12659\/msm.893697.","journal-title":"Med Sci Monit"},{"key":"7593_CR58","doi-asserted-by":"publisher","unstructured":"Ula\u0144czyk Z, et al. \u201cAssociations of microRNAs, angiogenesis-regulating factors and cfh Y402H polymorphism-an attempt to search for systemic biomarkers in age-related macular degeneration,\u201d (in Eng). Int J Mol Sci. 20(22). https:\/\/doi.org\/10.3390\/ijms20225750. Nov 15 2019.","DOI":"10.3390\/ijms20225750"},{"key":"7593_CR59","doi-asserted-by":"publisher","unstructured":"Wu J, Jiang Y, Sun J, Sun X. \u201cIdentification and validation of an Aging-associated circRNA-miRNA-mRNA network in Neovascular age-related macular degeneration,\u201d (in Eng). Gerontology. 2023;69(10):1218\u201331. https:\/\/doi.org\/10.1159\/000531287.","DOI":"10.1159\/000531287"},{"issue":"14","key":"7593_CR60","first-page":"2317","volume":"52","author":"Y Yuan","year":"2011","unstructured":"Yuan Y, Miller DM, Groves P, Kao WW, Augsburger JJ, Liu C-Y. MicroRNA profiling of Peripheral blood monocytes from patients with dry age related macular degeneration. Invest Ophthalmol Visual Sci. 2011. [Online]. Available: 52(14):2317\u20132317. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2353408.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"7593_CR61","unstructured":"ClinicalTrials.gov. A dose escalation trial of an intravitreal injection of Sirna-027 in Patients with subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD). NCT00363714. https:\/\/clinicaltrials.gov\/study\/NCT00363714."},{"key":"7593_CR62","doi-asserted-by":"publisher","unstructured":"Kaiser PK, Symons RC, Shah SM, Quinlan EJ, Tabandeh H, Do DV, et al. RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027. Am J Ophthalmol. 2010;150(1):33\u201339.e2. PMID: 20609706. https:\/\/doi.org\/10.1016\/j.ajo.2010.02.006.","DOI":"10.1016\/j.ajo.2010.02.006"},{"key":"7593_CR63","unstructured":"ClinicalTrials.gov. A study using intravitreal injections of a small interfering RNA in patients with age-related macular degeneration. NCT00395057. https:\/\/clinicaltrials.gov\/study\/NCT00395057."},{"key":"7593_CR64","doi-asserted-by":"publisher","unstructured":"Garba AO, Mousa SA. Bevasiranib for the treatment of wet, age-related macular degeneration. Ophthalmol Eye Dis. 2010;2:75\u201383. PMID: 23861616; PMCID: PMC3661434. https:\/\/doi.org\/10.4137\/OED.S4878.","DOI":"10.4137\/OED.S4878"},{"key":"7593_CR65","unstructured":"ClinicalTrials.gov. Evaluation of OLX10212 in patients with neovascular age-related macular degeneration. NCT05643118. https:\/\/clinicaltrials.gov\/study\/NCT05643118."},{"key":"7593_CR66","unstructured":"ClinicalTrials.gov. A randomized, double masked, parallel group, dose-finding study to evaluate SYL1801 in patients with neovascular Age-related Macular Degeneration (AMD). NCT05637255. https:\/\/clinicaltrials.gov\/study\/NCT05637255."},{"key":"7593_CR67","unstructured":"ClinicalTrials.gov. Cell collection to study eye diseases. NCT01432847. https:\/\/clinicaltrials.gov\/study\/NCT01432847."},{"key":"7593_CR68","doi-asserted-by":"publisher","unstructured":"Chen KY, Chan HC, Chan CM. Can stem cell therapy revolutionize ocular disease treatment? A critical review of preclinical and clinical advances. Stem Cell Rev Rep. 2025;21(5):1160\u20131185. Epub 2025 Apr 23. PMID: 40266467. https:\/\/doi.org\/10.1007\/s12015-025-10884-x.","DOI":"10.1007\/s12015-025-10884-x"},{"key":"7593_CR69","doi-asserted-by":"publisher","unstructured":"Chen KY, Chan HC, Chan CM. Can gene therapy transform the treatment landscape of posterior segment eye diseases? A comprehensive review of recent advancements. Drugs. 2025;85(12):1585\u20131608. Epub 2025 Oct 25. PMID: 41138048; PMCID: PMC12615577. https:\/\/doi.org\/10.1007\/s40265-025-02237-2.","DOI":"10.1007\/s40265-025-02237-2"},{"key":"7593_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.molimm.2016.11.016","volume":"84","author":"MJ Geerlings","year":"2017","unstructured":"Geerlings MJ, de Jong EK, den Hollander AI. The complement system in age-related macular degeneration: a review of rare genetic variants and implications for personalized treatment. (in Eng), Mol Immunol. 2017, Apr;84:65\u201376. https:\/\/doi.org\/10.1016\/j.molimm.2016.11.016.","journal-title":"(In Eng), Mol Immunol"},{"key":"7593_CR71","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.preteyeres.2017.09.001","volume":"62","author":"CB Toomey","year":"2018","unstructured":"Toomey CB, Johnson LV, Rickman CB. Complement factor H in AMD: bridging genetic associations and pathobiology. (in Eng), Prog Retin Eye Res. 2018, Jan;62:38\u201357. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.09.001.","journal-title":"(In Eng), Prog Retin Eye Res"},{"key":"7593_CR72","doi-asserted-by":"publisher","unstructured":"Frizziero L, et al. Hyperreflective retinal foci (HRF): definition and role of an invaluable oct sign. (in Eng), J Clin Med. 2025, Apr, 27;14(9). https:\/\/doi.org\/10.3390\/jcm14093021.","DOI":"10.3390\/jcm14093021"},{"key":"7593_CR73","doi-asserted-by":"publisher","unstructured":"Chen KY, Chan HC, Chan CM. Can bionic eyes restore vision? Breakthroughs, challenges, and future frontiers in ophthalmology - a comprehensive review,\u201d (in Eng). J Biol Eng. 2025, Nov, 27;19(1):106. https:\/\/doi.org\/10.1186\/s13036-025-00548-2.","DOI":"10.1186\/s13036-025-00548-2"},{"issue":"1","key":"7593_CR74","doi-asserted-by":"publisher","first-page":"11192","DOI":"10.1038\/s41598-023-38367-4","volume":"13","author":"R Han","year":"2023","unstructured":"Han R, et al. \u201cMicroRNA-146a negatively regulates inflammation via the IRAK1\/TRAF6\/NF-\u03baB signaling pathway in dry eye,\u201d (in Eng). Sci Rep. 2023, Jul, 11;13(1):11192. https:\/\/doi.org\/10.1038\/s41598-023-38367-4.","journal-title":"Sci Rep"},{"key":"7593_CR75","doi-asserted-by":"publisher","first-page":"3958453","DOI":"10.1155\/2016\/3958453","volume":"2016","author":"EA Ye","year":"2016","unstructured":"Ye EA, Steinle JJ. miR-146a attenuates inflammatory pathways mediated by TLR4\/NF-\u03baB and TNF\u03b1 to protect primary human retinal microvascular endothelial cells grown in high glucose. (in Eng), Mediators Inflamm. 2016;2016:3958453. https:\/\/doi.org\/10.1155\/2016\/3958453.","journal-title":"(In Eng), Mediators Inflamm"},{"key":"7593_CR76","doi-asserted-by":"publisher","first-page":"186872","DOI":"10.1155\/2013\/186872","volume":"2013","author":"J Guedes","year":"2013","unstructured":"Guedes J, Cardoso AL, de Lima MCP. Involvement of microRNA in microglia-mediated immune response. (in Eng), Clin Dev Immunol. 2013;2013:186872. https:\/\/doi.org\/10.1155\/2013\/186872.","journal-title":"(In Eng), Clin Dev Immunol"},{"key":"7593_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fnagi.2019.00137","volume":"11","author":"N Tong","year":"2019","unstructured":"Tong N, Jin R, Zhou Z, Wu X. Involvement of microRNA-34a in age-related susceptibility to oxidative stress in ARPE-19 cells by targeting the silent mating type information regulation 2 homolog 1\/p66shc pathway: implications for Age-related macular degeneration. (in Eng), Front Aging Neurosci. 2019;11:137. https:\/\/doi.org\/10.3389\/fnagi.2019.00137.","journal-title":"(In Eng), Front Aging Neurosci"},{"issue":"1","key":"7593_CR78","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/imr.13264","volume":"319","author":"SA Lieffrig","year":"2023","unstructured":"Lieffrig SA, Gyimesi G, Mao Y, Finnemann SC. Clearance phagocytosis by the retinal pigment epithelial during photoreceptor outer segment renewal: molecular mechanisms and relation to retinal inflammation. Immunological Rev. 2023;319(1):81\u201399.","journal-title":"Immunological Rev"},{"key":"7593_CR79","doi-asserted-by":"publisher","unstructured":"Price HB, et al. Development of next generation low-cost oct towards improved point-of-care retinal imaging. (in Eng), Biomed Opt Express. 16(2):748\u201359. https:\/\/doi.org\/10.1364\/boe.551625. Feb 1 2025.","DOI":"10.1364\/boe.551625"},{"key":"7593_CR80","doi-asserted-by":"publisher","unstructured":"Fujimoto JG, Pitris C, Boppart SA, Brezinski ME. \u201cOptical coherence tomography: an emerging technology for biomedical imaging and optical biopsy,\u201d (in eng). Neoplasia. 2000, Jan-Apr;2(1\u20132):9\u201325. https:\/\/doi.org\/10.1038\/sj.neo.7900071.","DOI":"10.1038\/sj.neo.7900071"},{"key":"7593_CR81","doi-asserted-by":"publisher","unstructured":"Chatterjee N, Rana S, Espinosa-Diez C, Anand S. \u201cMicroRNAs in Cancer: challenges and opportunities in early detection, disease monitoring, and therapeutic agents,\u201d (in Eng). Curr Pathobiol Rep. 2017, Mar;5(1):35\u201342. https:\/\/doi.org\/10.1007\/s40139-017-0123-0.","DOI":"10.1007\/s40139-017-0123-0"},{"issue":"28","key":"7593_CR82","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","volume":"43","author":"GAD Metcalf","year":"2024","unstructured":"Metcalf GAD. \u201cMicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances,\u201d (in eng). Oncogene. 2024, Jul;43(28):2135\u201342. https:\/\/doi.org\/10.1038\/s41388-024-03076-3.","journal-title":"Oncogene"},{"key":"7593_CR83","doi-asserted-by":"publisher","unstructured":"Chen KY, Chan HC, Chan CM. Is there a link between dry eye disease and diabetes mellitus? A systematic review and meta-analysis,\u201d (in eng). J Diabetes Complications. 2025, Oct;39(10):109149. https:\/\/doi.org\/10.1016\/j.jdiacomp.2025.109149.","DOI":"10.1016\/j.jdiacomp.2025.109149"},{"key":"7593_CR84","doi-asserted-by":"publisher","unstructured":"Chen KY, Chan HC, Chan CM. Does semaglutide increase the risk of non-arteritic anterior ischemic optic neuropathy? A systematic review and meta-analysis of emerging evidence. (in Eng), Asia Pac J Ophthalmol (Phila). 100245. https:\/\/doi.org\/10.1016\/j.apjo.2025.100245. Sep 15 2025.","DOI":"10.1016\/j.apjo.2025.100245"},{"key":"7593_CR85","doi-asserted-by":"crossref","unstructured":"Wozniak MB, Scelo G, Muller DC, Mukeria A, Zaridze D, Brennan P. Circulating microRNAs as noninvasive biomarkers for early detection of nonsmallcell lung cancer. PLoS One. 2015;10(5):e0125026.","DOI":"10.1371\/journal.pone.0125026"},{"key":"7593_CR86","doi-asserted-by":"publisher","unstructured":"Janssen HL, et al. \u201cTreatment of HCV infection by targeting microRNA,\u201d (in eng). N Engl J Med. 2013, May, 2;368(18):1685\u201394. https:\/\/doi.org\/10.1056\/NEJMoa1209026.","DOI":"10.1056\/NEJMoa1209026"},{"key":"7593_CR87","doi-asserted-by":"publisher","unstructured":"Hong DS, et al. \u201cPhase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours,\u201d (in Eng). Br J Cancer. 2020, May;122(11):1630\u201337. https:\/\/doi.org\/10.1038\/s41416-020-0802-1.","DOI":"10.1038\/s41416-020-0802-1"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07593-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:34:21Z","timestamp":1773830061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07593-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7593"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07593-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study does not involve human participants, human data or human tissue.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study does not involve individual data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"382"}}